Three-dimensional Quantitative Evaluation Method in <sup>123</sup>I-MIBG Myocardial SPECT-CT-Reference-Cited by-同舟云学术

Three-dimensional Quantitative Evaluation Method in <sup>123</sup>I-MIBG Myocardial SPECT-CT

Published:2023 Issue:1 Volume:79 Page:25-37
ISSN:0369-4305
Container-title:Japanese Journal of Radiological Technology
language:en
Short-container-title:Nippon Hoshasen Gijutsu Gakkai Zasshi

Author:

Yasumoto Yoshiaki¹,Daisaki Hiromitsu²,Nakahara Tadaki³,Ito Ryoichi¹,Fujita Isao¹

Affiliation:

1. Department of Radiology, Saitama City Hospital

2. Gunma Prefectural College of Health Sciences

3. Iwai Orthopaedic Medical Hospital

Publisher

Japanese Society of Radiological Technology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjrt/79/1/79_2023-1235/_pdf

Reference27 articles.

1. 1） Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989; 14(6): 1519–1526.

2. 2） Farget D, Wolf JE, Vanzetto G, et al. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med 1993; 34(1): 57–60.

3. 3） Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33(4): 471–477.

4. 4） Orimo S, Suzuki M, Inaba A, et al. ¹²³I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 2012; 18(5): 494–500.

5. 5） Orimo S, Ozawa E, Nakade S, et al. ¹²³I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999; 67(2): 189–194.